These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 9655880)
1. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). Zhang L; Schaner ME; Giacomini KM J Pharmacol Exp Ther; 1998 Jul; 286(1):354-61. PubMed ID: 9655880 [TBL] [Abstract][Full Text] [Related]
2. The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1. Zhang L; Gorset W; Dresser MJ; Giacomini KM J Pharmacol Exp Ther; 1999 Mar; 288(3):1192-8. PubMed ID: 10027858 [TBL] [Abstract][Full Text] [Related]
3. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2. Kimura N; Masuda S; Katsura T; Inui K Biochem Pharmacol; 2009 Apr; 77(8):1429-36. PubMed ID: 19426682 [TBL] [Abstract][Full Text] [Related]
4. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. Yabuuchi H; Tamai I; Nezu J; Sakamoto K; Oku A; Shimane M; Sai Y; Tsuji A J Pharmacol Exp Ther; 1999 May; 289(2):768-73. PubMed ID: 10215651 [TBL] [Abstract][Full Text] [Related]
5. Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system. Zhang L; Gorset W; Washington CB; Blaschke TF; Kroetz DL; Giacomini KM Drug Metab Dispos; 2000 Mar; 28(3):329-34. PubMed ID: 10681378 [TBL] [Abstract][Full Text] [Related]
6. Regulation of the human organic cation transporter hOCT1. Ciarimboli G; Struwe K; Arndt P; Gorboulev V; Koepsell H; Schlatter E; Hirsch JR J Cell Physiol; 2004 Dec; 201(3):420-8. PubMed ID: 15389554 [TBL] [Abstract][Full Text] [Related]
7. Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters. Kang HJ; Lee SS; Lee CH; Shim JC; Shin HJ; Liu KH; Yoo MA; Shin JG Drug Metab Dispos; 2006 Jul; 34(7):1145-51. PubMed ID: 16624869 [TBL] [Abstract][Full Text] [Related]
8. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). Yonezawa A; Masuda S; Yokoo S; Katsura T; Inui K J Pharmacol Exp Ther; 2006 Nov; 319(2):879-86. PubMed ID: 16914559 [TBL] [Abstract][Full Text] [Related]
9. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. Urakami Y; Okuda M; Masuda S; Saito H; Inui KI J Pharmacol Exp Ther; 1998 Nov; 287(2):800-5. PubMed ID: 9808712 [TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of two human polyspecific organic cation transporters. Gorboulev V; Ulzheimer JC; Akhoundova A; Ulzheimer-Teuber I; Karbach U; Quester S; Baumann C; Lang F; Busch AE; Koepsell H DNA Cell Biol; 1997 Jul; 16(7):871-81. PubMed ID: 9260930 [TBL] [Abstract][Full Text] [Related]
11. Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1). Dresser MJ; Gray AT; Giacomini KM J Pharmacol Exp Ther; 2000 Mar; 292(3):1146-52. PubMed ID: 10688634 [TBL] [Abstract][Full Text] [Related]
12. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3). Bourdet DL; Pritchard JB; Thakker DR J Pharmacol Exp Ther; 2005 Dec; 315(3):1288-97. PubMed ID: 16141367 [TBL] [Abstract][Full Text] [Related]
13. Cloning and functional expression of a mouse liver organic cation transporter. Green RM; Lo K; Sterritt C; Beier DR Hepatology; 1999 May; 29(5):1556-62. PubMed ID: 10216142 [TBL] [Abstract][Full Text] [Related]
14. The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2. Jouan E; Le Vee M; Denizot C; Da Violante G; Fardel O Fundam Clin Pharmacol; 2014 Feb; 28(1):65-77. PubMed ID: 22913740 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates. Umehara KI; Iwatsubo T; Noguchi K; Kamimura H Xenobiotica; 2007 Jun; 37(6):618-34. PubMed ID: 17614008 [TBL] [Abstract][Full Text] [Related]
16. Cloning and functional expression of a human liver organic cation transporter. Zhang L; Dresser MJ; Gray AT; Yost SC; Terashita S; Giacomini KM Mol Pharmacol; 1997 Jun; 51(6):913-21. PubMed ID: 9187257 [TBL] [Abstract][Full Text] [Related]
17. Development and characterization of an immobilized human organic cation transporter based liquid chromatographic stationary phase. Moaddel R; Yamaguchi R; Ho PC; Patel S; Hsu CP; Subrahmanyam V; Wainer IW J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):263-8. PubMed ID: 15734168 [TBL] [Abstract][Full Text] [Related]
18. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites. Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489 [TBL] [Abstract][Full Text] [Related]
19. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). Müller J; Lips KS; Metzner L; Neubert RH; Koepsell H; Brandsch M Biochem Pharmacol; 2005 Dec; 70(12):1851-60. PubMed ID: 16263091 [TBL] [Abstract][Full Text] [Related]
20. Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes. Inazu M; Takeda H; Matsumiya T J Neurochem; 2005 Sep; 94(5):1427-37. PubMed ID: 16000150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]